Danaher Corporation $DHR Shares Purchased by Bank Pictet & Cie Europe AG

Key Points

• Bank Pictet & Cie Europe AG increased its stake in Danaher Corporation by 34.0% during Q2, owning 261,271 shares valued at approximately $51.6 million.
• Danaher recently announced a quarterly dividend of $0.32 per share, reflecting an annualized yield of 0.7% and a payout ratio of 27.23%.
• Seventeen investment analysts have rated Danaher as a Buy, with a consensus target price of $245.91, while Bank of America has set a new target of $220.00.

Bank Pictet & Cie Europe AG raised its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 34.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 261,271 shares of the conglomerate's stock after purchasing an additional 66,361 shares during the period. Danaher comprises about 1.1% of Bank Pictet & Cie Europe AG's portfolio, making the stock its 26th largest holding. Bank Pictet & Cie Europe AG's holdings in Danaher were worth $51,611,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of DHR. Hills Bank & Trust Co lifted its holdings in Danaher by 0.3% in the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock worth $3,693,000 after acquiring an additional 53 shares during the last quarter. Sageworth Trust Co raised its position in shares of Danaher by 2.3% during the 1st quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock worth $493,000 after purchasing an additional 54 shares during the period. 1834 Investment Advisors Co. raised its position in shares of Danaher by 3.3% during the 1st quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate's stock worth $342,000 after purchasing an additional 54 shares during the period. Bruce G. Allen Investments LLC boosted its position in Danaher by 13.1% during the 2nd quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate's stock valued at $92,000 after purchasing an additional 54 shares during the period. Finally, Rakuten Securities Inc. boosted its position in Danaher by 33.3% during the 1st quarter. Rakuten Securities Inc. now owns 224 shares of the conglomerate's stock valued at $46,000 after purchasing an additional 56 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on DHR shares. Bank of America cut their target price on Danaher from $230.00 to $220.00 and set a "buy" rating on the stock in a research note on Monday. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research report on Tuesday, September 2nd. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Finally, Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $245.91.

Insider Activity

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Stock Performance

Shares of NYSE DHR opened at $181.56 on Friday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The firm has a market cap of $130.01 billion, a P/E ratio of 38.63, a PEG ratio of 2.65 and a beta of 0.75. The stock has a fifty day moving average price of $199.54 and a two-hundred day moving average price of $197.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the business earned $1.72 EPS. The company's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. Danaher's dividend payout ratio (DPR) is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.